• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感患儿单次静脉注射帕拉米韦后的免疫反应。

Immune response after a single intravenous peramivir administration in children with influenza.

作者信息

Sato Masatoki, Hashimoto Koichi, Kawasaki Yukihiko, Hosoya Mitsuaki

机构信息

Department of Paediatrics, Fukushima Medical University, Fukushima, Japan.

出版信息

Antivir Ther. 2018;23(5):435-441. doi: 10.3851/IMP3222.

DOI:10.3851/IMP3222
PMID:29372885
Abstract

BACKGROUND

Immune response after intravenous peramivir administration, which is approved for children with influenza infection in Japan, is unclear.

METHODS

Kinetics of viral load and serum cytokine levels before and after peramivir therapy were analysed in 17 and 8 hospitalized children infected with influenza A and B, respectively. Additionally, haemagglutination inhibition (HI) titre was measured. The first day of hospital admission was defined as day 0.

RESULTS

Serum interleukin (IL)-6 levels in influenza-A-infected children significantly decreased after peramivir administration, unlike in those with influenza B where a decrease on day 1 was followed by an increase on day 2. Serum IL-6 kinetics were similar to viral load kinetics in both influenza-A- and B-infected children between days 0 and 2. Serum IL-8 levels gradually decreased after peramivir therapy in influenza-A-infected children but increased between days 1 and 2 in influenza-B-infected children. Conversely, serum IL-10 levels gradually decreased over time. Serum interferon-γ and granulocyte macrophage colony-stimulating factor levels remained low until day 5. Day 0-4 serum HI titres were <4-fold in all children infected with influenza A or B. Additionally, day 5 HI titres were positive in 4 of 6 influenza A cases and all 3 influenza B cases.

CONCLUSIONS

Our results suggest that viral load and inflammatory cytokine kinetics were associated with the antiviral therapy used and that second peramivir administration should be considered in influenza B. The results also highlight antiviral agents as key determinants of the clinical course of influenza virus infection in children.

摘要

背景

在日本已获批用于流感感染儿童的静脉注射帕拉米韦后的免疫反应尚不清楚。

方法

分别对17例甲型流感和8例乙型流感住院患儿在帕拉米韦治疗前后的病毒载量动力学和血清细胞因子水平进行分析。此外,还测量了血凝抑制(HI)滴度。入院第一天定义为第0天。

结果

甲型流感感染患儿在给予帕拉米韦后血清白细胞介素(IL)-6水平显著下降,而乙型流感感染患儿在第1天下降后第2天又升高。在第0天至第2天期间,甲型和乙型流感感染患儿的血清IL-6动力学与病毒载量动力学相似。甲型流感感染患儿在接受帕拉米韦治疗后血清IL-8水平逐渐下降,而乙型流感感染患儿在第1天至第2天期间升高。相反,血清IL-10水平随时间逐渐下降。血清干扰素-γ和粒细胞巨噬细胞集落刺激因子水平在第5天前一直较低。所有甲型或乙型流感感染患儿在第0天至第4天的血清HI滴度均<4倍。此外,6例甲型流感病例中有4例在第5天HI滴度呈阳性,3例乙型流感病例全部呈阳性。

结论

我们的结果表明,病毒载量和炎性细胞因子动力学与所使用的抗病毒治疗相关,对于乙型流感应考虑再次给予帕拉米韦。这些结果还突出了抗病毒药物是儿童流感病毒感染临床病程的关键决定因素。

相似文献

1
Immune response after a single intravenous peramivir administration in children with influenza.流感患儿单次静脉注射帕拉米韦后的免疫反应。
Antivir Ther. 2018;23(5):435-441. doi: 10.3851/IMP3222.
2
Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.单次给药后流感病毒载量及帕拉米韦动力学,以及针对耐药变异株的帕拉米韦给药方案建议
Antimicrob Agents Chemother. 2015 Mar;59(3):1643-9. doi: 10.1128/AAC.04263-14. Epub 2014 Dec 29.
3
A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.一项比较静脉注射帕拉米韦与口服奥司他韦治疗住院成人季节性流感的临床试验。
Antivir Ther. 2013;18(5):651-61. doi: 10.3851/IMP2442. Epub 2012 Oct 30.
4
Intravenous peramivir for treatment of influenza in hospitalized patients.静脉注射帕拉米韦用于住院患者流感的治疗。
Antivir Ther. 2014;19(4):349-61. doi: 10.3851/IMP2680. Epub 2013 Aug 28.
5
Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.2009-2010 年和 2010-2011 年流感季节日本大流行和季节性流感病毒的神经氨酸酶抑制剂敏感性特征。
Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17.
6
Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.用神经氨酸酶抑制剂治疗甲型H1N1/09大流行流感患儿与甲型H3N2流感患儿后病毒排泄情况与发热持续时间的比较。
Antivir Ther. 2015;20(1):49-55. doi: 10.3851/IMP2798. Epub 2014 May 16.
7
The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.与口服奥司他韦相比,静脉注射帕拉米韦对小鼠流感后肺炎球菌肺炎结局的影响。
Antivir Ther. 2015;20(1):11-9. doi: 10.3851/IMP2744. Epub 2014 Feb 12.
8
Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.神经氨酸酶抑制剂——奥司他韦、扎那米韦、拉尼米韦和帕拉米韦——治疗甲型流感 H3N2 和 A(H1N1)pdm09 感染的临床效果:2010-2011 年日本流感季节的观察性研究。
J Infect Chemother. 2012 Dec;18(6):858-64. doi: 10.1007/s10156-012-0428-1. Epub 2012 May 29.
9
Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.静脉滴注帕拉米韦治疗重症甲型 H1N1 流感。
PLoS One. 2012;7(6):e40261. doi: 10.1371/journal.pone.0040261. Epub 2012 Jun 29.
10
Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.静脉滴注帕拉米韦治疗儿童 2009 年甲型 H1N1 流感病毒感染的疗效、安全性和药代动力学。
Antimicrob Agents Chemother. 2012 Jan;56(1):369-77. doi: 10.1128/AAC.00132-11. Epub 2011 Oct 24.

引用本文的文献

1
Risk Prediction of Coronary Artery Stenosis in Patients with Coronary Heart Disease Based on Logistic Regression and Artificial Neural Network.基于逻辑回归和人工神经网络的冠心病患者冠状动脉狭窄风险预测。
Comput Math Methods Med. 2022 Mar 19;2022:3684700. doi: 10.1155/2022/3684700. eCollection 2022.
2
Efficacy of Neuraminidase Inhibitors against H5N6 Highly Pathogenic Avian Influenza Virus in a Nonhuman Primate Model.神经氨酸酶抑制剂在非人灵长类动物模型中抗H5N6高致病性禽流感病毒的疗效
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.02561-19.
3
Antibody dynamics in Japanese paediatric patients with influenza A infection treated with neuraminidase inhibitors in a randomised trial.
神经氨酸酶抑制剂治疗的甲型流感感染日本儿科患者的抗体动态:一项随机试验。
Sci Rep. 2019 Aug 15;9(1):11891. doi: 10.1038/s41598-019-47884-0.